Phase II Study of Gemcitabine and Cisplatin as First Line Combination Therapy in Patients With Triple-negative MBC.
Phase of Trial: Phase II
Latest Information Update: 01 Jan 2015
At a glance
- Drugs Cisplatin (Primary) ; Gemcitabine (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 30 Jun 2011 Actual end date (Sep 2010) added as reported by ClinicalTrials.gov.
- 30 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.